Effects of tumor necrosis factor gene polymorphisms on patients with congestive heart failure

Circulation

Volumn 97, Issue 25, 1998, Pages 2499-2501

  Kubota, Toru ^a   McNamara, Dennis M ^a   Wang, Jue J ^a   Trost, Mary ^a   McTiernan, Charles F ^a   Mann, Douglas L ^b   Feldman, Arthur M ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Genetics; Heart failure; Immunology

Indexed keywords

TUMOR NECROSIS FACTOR;

ADULT; AGED; ALLELE; ARTICLE; CASE REPORT; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC PREDISPOSITION; GENOTYPE; HEART FAILURE; HUMAN; INFLAMMATORY DISEASE; INTRON; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0032581020     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.25.2499     Document Type: Article

References (15)

1. Levine B, Kaiman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;223:236-241.
2. Ferrari R, Bacheni T, Confortini R, Opasich C, Febo O, Corti A, Cassani G, Visioli O. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation. 1995;92: 1479-1486.
3. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol. 1996;27:1201-1206.
4. Nozaki N, Yamaguchi S, Shirakabe M, Nakamura H, Tomoike H. Soluble tumor necrosis factor receptors are elevated in relation to severity of congestive heart failure. Jpn Circ J. 1997;61:657-664.
5. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, Mann DL. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation. 1996;93:704-711.
6. Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP, Demetris AJ, Feldman AM. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-α. Circ Res. 1997;81:627-635.
7. Wilson AG, di Giovine FS, Duff GW. Genetics of tumor necrosis factor-α in autoimmune, infectious, and neoplastic diseases. J Inflamm. 1995;45:1-12.
8. Wilson AG, di Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the human tumor necrosis factor alpha (TNFα) gene detectable by NcoI restriction of PCR product. Hum Mol Genet. 1992; 1:353.
9. Messer G, Spengler U, Jung MC, Honold G, Blömer K, Pape GR, Riethmüller G, Weiss EH. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-β gene correlates with a variant amino acid in position 26 and a reduced level of TNF-β production. J Exp Med. 1991;173:209-219.
10. Wilson AG, Symons JA, McDowell TL, di Giovine FS, Duff GW. Effects of a tumor necrosis factor (TNFα) promoter base transition on transcriptional activity. Br J Rheumatol. 1994;33(suppl 1):89.
11. Stüber F, Petersen M, Bokelmann F, Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-α concentrations and outcome of patients with severe sepsis. Crit Care Med. 1996;24:381-384.
12. Stuber F, Udalova IA, Book M, Drutskaya LN, Kuprash D, Turetskaya RL, Shade FU, Nedospasov SA. -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J Inflamm. 1996;46:42-50.
13. Danis VA, Millington M, Hyland V, Lawford R, Huang Q, Grennan D. Increased frequency of the uncommon allele of a tumor necrosis factor alpha gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus. Dis Markers. 1994;12:127-133.
14. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwjatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature. 1994;371:508-511.
15. Fugger L, Morling N, Ryder LP, Georgsen J, Jakobsen BK, Svejgaard A, Andenen V, Oxholm P, Pedersen FK, Friis J, Halberg P. NcoI restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNFα) region in four autoimmune diseases. Tissue Antigen. 1989;34:17-22.